JPJohn F. Peroni

John F. Peroni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John F. Peroni has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An equine bone marrow aspirate concentrate protocol yields a predictable cellular and cytokine profile

    by Megan Branning, Julie Gordon, Samantha N. Schlemmer, John F. Peroni

    Background: Bone marrow aspirate concentrate (BMAC) is a quick, minimally invasive, point‐of‐care therapy for equine orthopaedic injuries. Despite growing clinical use, standardised manufacturing methods are lacking, and the final product remains poorly characterised. Objective: To develop a reproducible protocol for equine BMAC production that yields predictable cellular and cytokine compositions. Study Design: In vitro analytical study. Methods: Bone marrow aspirate (BMA) was harvested from the sternum of eight healthy adult horses and filtered to remove possible bony spicules. After centrifugation at 1000 × g for 10 min, the buffy coat was collected to generate BMAC. Cellular composition was assessed using standard haematology and cytology, and cytokine concentrations were measured using commercially available enzyme‐linked immunosorbent assay (ELISA) kits. Data are presented as mean ± standard deviation. Results: BMA filtration successfully removed potential bony material without significantly altering the cellular profile. Cells were predictably concentrated in BMAC: total nucleated cells increased from 77 ± 30 × 10 3 /μL to 240 ± 57 × 10 3 /μL; and platelets from 119 ± 34 × 10 3 /μL to 269 ± 81 × 10 3 /μL. Anti‐inflammatory cytokines were increased in BMAC: IL‐1ra increased from 18,611.3 ± 5509.1 to 36,598.8 ± 5971.8 pg/mL; IL‐10 from 9.0 ± 7.5 to 19.1 ± 15.6 ng/mL; and TGF‐β1 from 2535.0 ± 3018.7 to 5073.8 ± 2175.9 pg/mL. Of the pro‐inflammatory cytokines measured, only IL‐1β was increased (287.5 ± 22.5 to 475.1 ± 206.0 pg/mL), while TNF‐α and IL‐6 were unchanged. Main Limitations: The small cohort size ( n = 8) limited sensitivity for detecting minor effects. The cytokine panel, while representative, does not encompass all potential bioactive mediators, and single‐time‐point measurements do not necessarily reflect in vivo release kinetics. The clinical efficacy of BMAC was not evaluated, preventing direct correlation between compositional features and therapeutic outcomes. Conclusions: The BMAC protocol yielded consistently concentrated nucleated cells, preserved cellular morphology, and enhanced the anti‐inflammatory cytokine profile relative to post‐filtration BMA. These findings provide a biological rationale for intra‐articular and intra‐lesional use of BMAC in equine patients.

  • Open Access

    Equine platelet lysate shows in vitro antimicrobial activity after lyophilisation and storage

    by Hannah Arnade, Livia Camargo Garbin, Edward Hunda, Julie Gordon, John Peroni

    Background Platelet lysate (PL), an emerging biologic therapy, inhibits bacterial growth in vitro. Currently, PL is stored frozen at -80°C, which limits distribution and clinical access. Objectives To assess protein recovery and compare antimicrobial activity of PL before and immediately after lyophilisation, and after room-temperature storage. Study design Experimental in vitro study Methods Three pooled batches of PL from nine healthy equine donors were tested for cytokine content and in vitro efficacy in a time-kill assay as thawed PL, reconstituted freshly lyophilised PL (lyoPL), and reconstituted lyoPL stored for either 2 weeks or 6 months at room temperature (19–21°C). Time-kill assay focused on Escherichia coli and Staphylococcus haemolyticus. Experiments used a 50% (v/v) treatment in bacterial growth medium with phosphate-buffered saline (PBS) as control. Log₁₀ fold-changes in bacterial counts were compared between preparations using linear mixed-effects models and repeated-measures two-way ANOVA, with the pooled batch as the unit of replication (n = 3). Results LyoPL formulations contained similar total protein content to the fresh PL without necessitating addition of a cryobuffer. PDGF-BB was retained after lyophilisation, and immunoreactive CXCL4 (PF4) and CXCL7 concentrations did not differ between PL and lyoPL. Fresh lyoPL and thawed PL showed similar time-kill profiles. LyoPL retained antibacterial activity after 2 weeks and 6 months of storage. Against gram-positive S. haemolyticus, lyoPL and PL showed no significant differences irrespective of storage time and growth inhibition relative to PBS was preserved. Against gram-negative E. coli, PL and lyoPL stored for 2 weeks had a bactericidal effect whereas 6-month stored lyoPL was only bacteriostatic. Main limitations Three pooled batches, two bacterial isolates, one PL concentration, a 4-hour exposure period, and residual moisture not measured. Conclusions Lyophilised PL retained in vitro antimicrobial activity after reconstitution and room-temperature storage, with reduced activity against E. coli after 6 months.

  • Open Access

    Lameness 4 weeks after stabilization predicts long-term complications in small ruminants with long-bone fractures

    by David K. Cox, Madeline Bower, John Peroni

    Objective: To describe clinical features, management strategies, outcomes, and potential prognostic indicators for long-bone fractures in small ruminants. We hypothesized that complication rates would exceed those previously reported. Methods: This was a retrospective observational study evaluating sheep and goats with radiographically confirmed long-bone fractures treated at a single veterinary teaching hospital (December 2014 to July 2025). Medical records and radiographs were reviewed to characterize demographics, fracture features, treatments, and complications. Associations between variables and outcomes were explored with χ 2 and Kruskal-Wallis tests. Primary outcomes were short- and long-term complications. Results: 58 small ruminants with 69 fractures were included. Hind limb fractures predominated (38 of 58 [65.5%]); the most frequently affected bones were the metatarsus III/IV (21 of 69 [30.4%]) and tibia (15 of 69 [21.7%]). Most fractures were closed (56 of 69 [81.2%]) and complete (67 of 69 [97.1%]). Among stabilized animals, casting was the most common primary method (22 of 44 [50.0%]). Survival to discharge was 86.2% (50 of 58). Among animals with follow-up available, short- and long-term complications occurred in 24 of 31 (77.4%) and 17 of 23 (73.9%), respectively. Lameness at 4 weeks after stabilization was strongly associated with long-term complications. Conclusions: Long-bone fractures in small ruminants were associated with a high frequency of complications. Lameness 4 weeks after stabilization may be a clinically useful early indicator of poor long-term outcome. In this cohort, casting was most often associated with favorable outcomes in closed metatarsus III/IV fractures. Clinical Relevance: These results supported case selection and client counselling by identifying fracture characteristics for which casting may be most appropriate. Additionally, they highlighted poststabilization lameness as a potential prognostic indicator.

  • Open Access

    Impact of IL-6 and TGF-β1 on equine mesenchymal stromal cell homing gene expression

    by Jordan L. Parker, Londa J. Berghaus, Julie Gordon, Laura Mathews, Mary Ayobami Akinde, Daniel B. Hall, John F. Peroni


  • Open Access

    Three-dimensional tissue culture supports the structure and function of equine synovial explants over 4 days

    by Hannah Arnade, Irene E. Ivie, Julie Gordon, John F. Peroni

    Objective: To evaluate the feasibility of short-term 3-D tissue culture in maintaining the structure and function of equine synovial explants and demonstrate that day 4 explant characteristics were not significantly different from day 0. We hypothesized that a 4-day culture period in 3-D explant culture would not significantly disrupt synovial tissue health and function compared to baseline measurements. Methods: Synovial explants (n = 24/horse) from healthy carpal joints of 5 horses were cultured in 12-well plates using tissue-stabilizing agar rings. Explants were evaluated in triplicate or quadruplicate at days 0, 2, and 4 for metabolism, viability, histologic parameters, cytokine secretion, and hyaluronic acid production. Results: No tested parameters showed significant changes by day 4. Average cell viability was 87.99% (95% CId4–d0, −4.6% to 12.99%), and histologic grading showed slight but nonsignificant changes. Mitochondrial NADH production from pyruvate and malate on day 4 remained at 85% to 90% that of day 0 (Cohen d, 0.184, 0.153). Hyaluronic acid production over days 2 to 4 was 95.98% that of days 0 to 2 (95% CIday4/day2, 73.82% to 118.14%). Cytokine secretion showed nonsignificant decreases (TNFαday4/day2, 0.518; CI, 0.159 to 0.417; IL-1βday4/day2, 0.520; CI, 0.150 to 0.393). Explants exhibited macrophagic character by staining diffusely with anti-CD11b and CD14 antibodies. Conclusions: Our culture system repeatably maintained the structural and functional integrity of equine synovial explants over 4 days. Clinical Relevance: This study establishes a standardized method for culturing equine synovial explants to the aim of accurately modeling of joint diseases and the effects of articular therapeutics.

  • Open Access

    Diagnostic imaging and management of penetrating wounds of the foot

    by A. Scharf, J. Peroni

    Summary: Penetrating foot injuries in horses pose significant diagnostic and therapeutic challenges, particularly when deeper synovial structures are involved. A systematic approach to diagnostic imaging and early and aggressive management is essential to achieve a good outcome. While superficial wounds may resolve with conservative treatment, deeper injuries carry a high risk of complications, including osteomyelitis and synovial sepsis. Radiography, magnetic resonance imaging (MRI), and computed tomography (CT) play a crucial role in assessing the extent of injury and guiding treatment decisions. This commentary reviews progressive clinical approaches for diagnostic imaging and management of penetrating solar wounds in the horse.

  • Open Access

    Osteochondral allograft and xenograft immunogenicity decrease following ex vivo tissue culture

    by Kate E. Birdwhistell, Samuel P. Franklin, David J. Hurley, Bradley D. Heins, John F. Peroni


  • Equine Platelet Lysate Gel: A Matrix for Mesenchymal Stem Cell Delivery

    by Maria C. Naskou, Maria C. Naskou, Jesse F. Tyma, Jesse F. Tyma, Julie Gordon, Julie Gordon, Alysha Berezny, Alysha Berezny, Hannah Kemelmakher, Hannah Kemelmakher, et al.

    A variety of bio-scaffolds have been developed as carriers for the delivery of Mesenchymal Stem Cells (MSCs) however many of them are unable to provide direct cell nourishment, a critical factor for survival and retention of MSCs at the site of delivery. Platelet lysate (PL) is a plasma derived product rich in growth factors, that can be turned into a gel matrix following the addition of calcium chloride. Our objective was to characterize growth factor and cytokine release of equine PL gel (ePL gel) encapsulated with MSCs over time and to measure the viability and proliferation of ePL gel-encapsulated MSCs for up to 14 days. Release of interleukin-1β (IL-1β), interleukin-10 (IL-10), transforming growth factor beta (TGF-β), vascular endothelial growth factor (VEGF), and platelet derived growth factor (PDGF-BB), as well as fibrinogen degradation, were measured from ePL gel with and without equine bone marrow derived MSCs and compared to MSCs in monolayer. MSC proliferation and viability within the gel were assessed up to 14 days. Compared to monolayer MSC cultures, significantly higher concentrations of IL-1β, IL-10, and TGF-β were measured from supernatants collected from ePL gel containing MSCs at various time points. Significantly lower concentrations of PDGF-BB were measured in the supernatant when MSCs were incorporated in ePL gel while VEGF tended to be increased compared to MSCs in monolayer. Incorporation in ePL gel for up to 14 days did not appear to affect viability and proliferation rates of MSCs as these were found to be similar to those measured in monolayer cell culture. ePL gel may have the potential to serve as bio-scaffold for MSC delivery since it appears to support the proliferation and viability of MSCs for up to 14 days.


  • Open Access

    Antimicrobial Effects of Equine Platelet Lysate

    by Julie Gordon, Sonsiray Álvarez-Narváez, John F. Peroni

    The development of antimicrobial resistant bacteria and the lack of novel antibiotic strategies to combat those bacteria is an ever-present problem in both veterinary and human medicine. The goal of this study is to evaluate platelet lysate (PL) as a biological alternative antimicrobial product. Platelet lysate is an acellular platelet-derived product rich in growth factors and cytokines that is manufactured via plateletpheresis and pooled from donor horses. In the current study, we sought to define the antimicrobial properties of PL on select gram-positive and gram-negative bacteria. Results from an end-point in vitro assay showed that PL did not support bacterial growth, and in fact significantly reduced bacterial content compared to normal growth media. An in vitro assay was then utilized to further determine the effects on bacterial growth dynamics and showed that all strains exhibited a slower growth rate and lower yield in the presence of PL. The specific effects of PL were unique for each bacterial strain: E. coli and P. aeruginosa growth was affected in a concentration-dependent manner, such that higher amounts of PL had a greater effect, while this was not true for S. aureus or E. faecalis. Furthermore, the onset of exponential growth was delayed for E. coli and P. aeruginosa in the presence of PL, which has significant clinical implications for developing a dosing schedule. In conclusion, our findings demonstrate the potential value of PL as a broad-spectrum antimicrobial that would offer an alternative to traditional antibiotics for the treatment of bacterial infection in equine species.